924 studies found for:    glioblastoma multiforme
Show Display Options
Rank Status Study
1 Recruiting Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Condition: Glioblastoma Multiforme
Intervention: Other: ketogenic diet
2 Recruiting Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Interventions: Biological: Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy;   Biological: Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
3 Completed
Has Results
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
Conditions: Anaplastic Glioma of Brain;   Glioblastoma Multiforme;   Brain Cancer
Interventions: Drug: Capecitabine;   Drug: Celecoxib (Celebrex);   Drug: Temozolomide;   Drug: Lomustine;   Drug: 6-Thioguanine
4 Terminated
Has Results
TRC105 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: TRC105
5 Terminated Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: TLN-4601
6 Recruiting Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Radiation: Radiochemotherapy
7 Completed A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
8 Completed Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: XL184
9 Recruiting Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Brain Cancer;   Glioblastoma Multiforme
Interventions: Drug: Vorinostat;   Drug: Erlotinib;   Drug: Temozolomide
10 Withdrawn Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: TransMID™
11 Withdrawn Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
Condition: Glioblastoma Multiforme
Intervention: Drug: IL-4PE
12 Terminated
Has Results
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Drug: Everolimus;   Procedure: Surgery
13 Completed
Has Results
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Radiation: Radiation Therapy;   Drug: Temozolomide;   Drug: Sorafenib
14 Active, not recruiting Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
Conditions: Recurrent Glioblastoma Multiforme;   Recurrent Gliosarcoma
Intervention: Drug: temozolomide and bevacizumab
15 Recruiting BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
Conditions: GBM;   Glioblastoma Multiforme;   Gliosarcoma
Intervention: Drug: PSMA ADC
16 Terminated Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: temozolomide;   Procedure: Brachytherapy;   Procedure: External Beam Radiation Therapy
17 Unknown  SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: Sunitinib
18 Recruiting Randomized Phase II Multicentre Study to Investigate Efficacy of Autologous Lymphoid Effector Cells Specific Against Tumour-Cells (ALECSAT) in Patients With Glioblastoma Multiforme Measured Compared to Avastin/Irinotecan
Condition: Glioblastoma Multiforme
Interventions: Biological: ALECSAT;   Drug: Bevacizumab/Irinotecan
19 Recruiting Phase II Pazopanib Plus Topotecan for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Brain Neoplasms;   Central Nervous System Neoplasms
Interventions: Drug: Pazopanib;   Drug: Topotecan;   Behavioral: Symptom Questionnaire;   Behavioral: Phone Calls
20 Completed
Has Results
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
Condition: Glioblastoma Multiforme
Interventions: Radiation: Radiation therapy;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Everolimus

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years